Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|January 24, 2012
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphomaRebecca L Elstrom, Biree Andemariam, Peter Martin, et al.
Leukemia & Lymphoma|March 11, 2015
Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomasPeter Martin, Richard R Furman, Sarah Rutherford, et al.
American Journal of Clinical Pathology|November 21, 2009
Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma cloneCory R Fraser, Wei Wang, Mario Gomez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2019
Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysisYen-Chun Liu, Elizabeth Margolskee, John N Allan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphomaRanjana Advani, Andres Forero-Torres, Richard R Furman, et al.
Cancer Research|May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy ResponsesTiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Journal of Translational Medicine|May 8, 2007
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemiaDianne Pulte, Kim E Olson, M Johan Broekman, et al.
Blood|January 25, 2012
Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomasPankaj Gupta, David M Goldenberg, Edmund A Rossi, et al.
The American Journal of Surgical Pathology|October 9, 2015
Idelalisib-associated Colitis: Histologic Findings in 14 PatientsAnna-Sophie Weidner, Nicole C Panarelli, Julia T Geyer, et al.
Cancer|March 18, 2010
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphomaJia Ruan, Peter Martin, Morton Coleman, et al.
Pageof 14